Future Retirement Success
  • Politics
  • Business
  • Investing
  • Stocks
  • Politics
  • Business
  • Investing
  • Stocks

Future Retirement Success

Business

UK signs 10-year deal with Moderna to produce 250m vaccines in event of another pandemic

by December 23, 2022
December 23, 2022
UK signs 10-year deal with Moderna to produce 250m vaccines in event of another pandemic

The UK government has signed a 10-year deal with Moderna to produce upwards of 250m vaccines a year in the event of a pandemic.

The investment will give NHS patients access to UK-made mRNA vaccines while a new innovation and technology centre will be created, with 150 highly skilled jobs.

In a major boost for the UK as a life sciences superpower, it will also boost health research and lead to the UK Health Security Agency (UKHSA) working with Moderna in vaccine development.

The partnership, led by the Vaccine Taskforce , was announced in June of this year.

By producing vaccines in the UK, it will allow production to be massively scaled up in the event of a major health emergency, such as another pandemic or new covid variant.

Secretary of State for Health and Social Care, Steve Barclay, said: “This time 2 years ago, the UK was the first country in the world to administer a COVID vaccine outside of a clinical trial. Since then, countless lives have been saved across the world and more than 150 million doses have been given in the UK alone.”

“It is vital we invest in fighting future variants of this disease as well as other deadly viruses that are circulating, such as seasonal flu and RSV, and this partnership with Moderna will also strengthen our ability to respond to any future pandemics.

“By boosting our onshore vaccine manufacturing capability, we are a step closer to becoming the leading global hub for life sciences. This partnership will support our crucial mission to protect the people of the UK and across the world through the development of revolutionary vaccines and research.”

The deal was heralded by Dr Jenny Harries, Chief Executive of UKHSA, who said it “will now be taking this forward as a vital part of our preparedness against future respiratory virus threats, including COVID-19.”

“Our scientists have been monitoring the evolution of the virus throughout the pandemic, and assuring continued protection for the population. This partnership will take the winning ways of working with industry and build the nation’s resilience, giving us rapid access to vaccines. We look forward to working closely with Moderna and playing a key role in supporting the government’s ambitious life sciences strategy.”

Stéphane Bancel, Chief Executive Officer of Moderna, said: “Our new state-of-the-art facility will bring mRNA manufacturing to UK shores, providing the UK public with access to pandemic response capabilities through Moderna COVID-19 vaccines and future respiratory virus vaccine candidates.”

Richard Torbett, Chief Executive, Association of the British Pharmaceutical Industry (ABPI) said: “This partnership is fantastic news for British manufacturing and UK-based science and research. It is an important reminder that the Life Sciences Industry has the potential to be a key growth driver for the UK economy.”

Read more:
UK signs 10-year deal with Moderna to produce 250m vaccines in event of another pandemic

0
FacebookTwitterGoogle +Pinterest
previous post
Festive season fuels 2.5 million visits to the capital post-Covid
next post
Flexible office occupancy rates recover to pre-pandemic levels

You may also like

Ocado chief blames Reeves’s Budget for rising food...

July 18, 2025

Trump poised to reject Mandelson as UK ambassador...

January 23, 2025

Asda faces staff backlash after scrapping 10,000 manager...

March 1, 2025

Next CEO Lord Wolfson says planning rules are...

December 7, 2023

London finance sector sees seasonal hiring boost, but...

April 17, 2025

HMRC withheld offshore tax avoidance figures for UK’s...

July 7, 2024

Michelle Mone’s husband linked to three tax avoidance...

January 23, 2023

Fashion For Thought: Nailing Your Clothing Brands Identity

January 18, 2024

AI and Tech Startups to Get £100m Investment...

August 16, 2024

How can employers avoid problems at staff parties?

November 22, 2023

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • WATCH: Trump says he is hopeful Hillary Clinton will be investigated for election fraud

      August 1, 2025
    • Trump moves nuclear submarines weeks after praising sub’s power in Iran strikes

      August 1, 2025
    • Recess on ice as Republicans hunker down for high-stakes nominee blitz

      August 1, 2025
    • Iran says it has ‘plenty of scientists’ left to restart uranium enrichment, despite US, Israeli strikes

      August 1, 2025
    • No, Tariffs Are Not Similar to Consumption Taxes Like a VAT

      August 1, 2025
    • Trump repositions 2 nuclear submarines after ‘highly provocative’ Russian comments

      August 1, 2025

    Categories

    • Business (8,651)
    • Investing (2,168)
    • Politics (16,281)
    • Stocks (3,228)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: futureretirementsuccess.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 futureretirementsuccess.com | All Rights Reserved